请选择 进入手机版 | 继续访问电脑版
查看: 491|回复: 0

【联合活动】NECINA x MIT CHIEF 2018 Boston Digital Health Conference

[复制链接]

参加活动: 0

组织活动: 753

780

主题

780

帖子

3381

积分

管理员

Rank: 9Rank: 9Rank: 9

积分
3381
发表于 2018-12-11 21:16:23 | 显示全部楼层 |阅读模式
活动类型:
讲座
活动时间:
2018-12-15 01:00 PM 至 2018-12-15 05:00 PM 商定
活动地点:
MIT Ray and Maria Stata Center 32- Room 155 32 Vassar St, Cambridge, MA 02139
已报名人数:
0

活动评分

0

 

0(投票)

  •     5分 0.0%
  •     4分 0.0%
  •     3分 0.0%
  •     2分 0.0%
  •     1分 0.0%

  • 活动查看
  • 活动相册
  • 已通过
近年来,在人工智能引领医疗革命方面传出了许多振奋人心的消息。2017年美国医疗保健支出约3.5万亿美元(占美国GDP的19%),五年内从2012年的2.8万亿美元增长25%。通过研究人员采取的大量措施来降低医疗系统的成本,我们可以看出人工智能的应用在医疗保健中的巨大增长机会。

随着越来越多的健康和基因组数据研究的公开,人工智能驱动的技术正在推动医学知识的发现和医疗保健服务的创新。庞大的市场吸引了很多创业公司以及IBM、谷歌等大公司尝试通过人工智能改善医疗诊断,其中通过人工智能处理医学影像、数据分析等功能已经在多家医院临床实现。
微信图片_20181212101639.jpg
人工智能可将复杂、高维度的医学影像数据,降维使其更易处理,因而可以快速、准确地从医学影像中发现病症的信息,还可以实现早筛早查,帮助患者尽早发现并及时治疗。
微信图片_20181212101645.jpg
人工智能还可以优化管理工作流程,提升诊疗效率,辅助医生诊断,同时解放医生,让更多人获得高质量、高效率医疗服务。

然而,人工智能在医疗方面的实际实施仍然面临着多重挑战:目前的监管缺乏评估人工智能系统安全性和有效性的标准;数据交换的继续可能成为维持AI系统的障碍,因为当前的医疗基础设施不能提供数据共享的激励。尽管许多AI应用程序一直在帮助临床医生提高工作效率,但临床决策仍然很少。克服这些问题需要医疗保健和技术社区之间的密切合作,这是本次会议将要探讨的议题。
微信图片_20181212101650.jpg
本次会议将汇集一群杰出的医疗保健从业者,生命科学研究人员,数据科学家,技术专家和企业家,分享他们的深入知识,以及数据科学和人工智能技术如何推动提高患者的医疗质量,提高系统效率,减少成本,等等。

2018 Boston Digital Health Conference

时间:12月15日 下午1-5pm
地点:MIT Ray and Maria Stata Center
        32- Room 155
        32 Vassar St, Cambridge, MA 02139
费用:$20/ per person
           NECINA会员及学生免费
报名方式:请扫码以下二维码或点击文末左下角阅读全文(Read More)前往Eventbrite注册报名
微信图片_20181212101655.jpg

嘉宾介绍 (排名不分先后):
微信图片_20181212101701.jpg
Ji-Xin Cheng
Moustakas Professor (ECE, BME)
Boston University
Professor Cheng is currently Moustakas Professor (ECE, BME) at Boston University. He and his team have been constantly at the most forefront of the rising field of label-free optical spectroscopic imaging in technology, science, and clinical translation. His research has been supported by over 25 million ($) fund from federal agencies and private foundations. Cheng is authored in over 220 peer-reviewed articles with an h-index of 69 (Google Scholar). He organized/chaired 26 national/ international symposia, delivered over 200 invited talks. He holds 10 US patents for the invention of CARS microscope and other technologies. He is the lead editor of the first book on coherent Raman scattering microscopy, CRC Press, 2012. In 2014 He co-founded Vibronix Inc which has the mission of saving lives through medical device innovations.
Professor Cheng has been recognized by Fellow of Optical Society of America (2018), SPIE Translational Research Awards (2018, 2016, 2014), Purdue University College of Engineering Research Excellence Award (2016), Craver Award from Coblentz Society (2015), Chang-Jiang Scholar from Chinese Minister of Education (2015), Fellow of American Institute of Medicine and Biological Engineering (2014), Purdue University Faculty Scholar (2012-17), College of Engineering Early Career Research Award (2011), Research Excellence Award from Purdue Center for Cancer Research (2011), Outstanding Young Scientist Award from Chinese National Academy of Sciences (2009).
微信图片_20181212101707.jpg
Dennis Grishin
Cofounders, Nebula Genomics
Forbes Healthcare 30 under 30
Research Assistant, PI Church at Harvard Medical School
Dennis Grishin and Kamal Obbad are bringing blockchain to the genome. Working with Harvard idea-factory George Church, they created a technology that helps people protect and share their genetic code--and be paid for doing so. Their company, Nebula Genomics, has raised $4.5 million from investors such as Khosla Ventures, Arch Venture Partners and F-Prime Capital.
微信图片_20181212101712.jpg
Cao (Danica) Xiao
Research Staff Member in AI for Healthcare
IBM Research
Cao (Danica) Xiao is a Research Staff Member in the AI for Healthcare Team of IBM Research AI, located in Cambridge, Massachusetts. Before joining IBM, she got her Ph.D. degree from University of Washington, Seattle in 2016. Her thesis focused on machine learning and data mining with medical and healthcare applications.
Her research interests focus on developing machine learning and deep learning models to solve real world healthcare challenges. Particularly, she is interested in deep computational phenotyping, adverse drug reaction signal detection from heterogeneous real world evidence, causal inference from observational data, and translational informatics research (e.g., drug similarity for drug safety and discovery).
微信图片_20181212101718.jpg
Da Zhang, Ph.D.
Assistant Professor of Radiology at Harvard Medical School
Dr. Zhang obtained his PhD from University of Oklahoma. He is now an assistant professor at of Radiology at Harvard Medical School and a medical imaging physicist at Beth Israel Deaconess Medical Center. His research interest: Informatics in Radiology, Machine Learning, Data Science, Medical Imaging Physics, Radiation Dose and Imaging Performance Monitoring and Management.
微信图片_20181212101722.jpg
Zhang Chen, PhD
Data Scientist at Dana-Farber Cancer Institute
Dr. Chen obtained his PhD from University of Pennsylvania and worked at Thomas Jefferson Hospital as a data scientist. His research is mainly focused on developing statistical and machine learning models for biomedical data analysis. His current work involves analyzing genomics, EHR, image, clinical text data as well as hospital operational data to improve healthcare in the hospital.

Startup Showcase
此外,本次会议除了邀请高水平的speaker,还准备了startup showcase环节。我们荣幸地邀请到以下优秀的初创公司参加。每个公司将有7分钟的Presentation和3分钟的Q&A。
微信图片_20181212102008.jpg
该公司由哈佛“遗传学大牛”George Church牵头,联合哈佛Dennis Grishin博士、Kamal Obbad博士等人共同创立,致力于革新消费级基因测序,让客户能够真正拥有自己的测序数据。
微信图片_20181212102020.jpg
Vibronix, Inc. is a medical device company that aims to provide precise disease diagnosis and treatment. Powered by its tech engine in advanced bio-photonics, Vibronix now has three technology platforms: Coherent Raman Scattering Imaging, Photoacoustic Imaging and Optical Sensing. Vibronix’s latest product: CARSA-Coherent Anti-stokes Raman Scattering imaging for Antibiotic Susceptibility test will be presented for the first time. Antimicrobial resistance causes nearly 1 million deaths from drug-resistant infections each year globally. If no action taken, over 10 million deaths and $100 trillion GDP loss will be expected by 2050. To combat this crisis, we develop CARSA to shorten the current 2-days antibiotics susceptibility test into 10 minutes to gain precious time to save more lives. To date, Vibronix has received 4 STTR/SBIR grants from NIH and NSF.
微信图片_20181212102025.jpg
VitaData, a decentralized health data exchange powered by blockchain. The Vitadata Way is collaboration with best-in-class technology providers and resellers so as to bring data to life for the communities we serve.
微信图片_20181212102030.jpg
ChaveTech智医惠民科技团队,专注于家庭医生领域的互联网科技团队,用科技助力医疗:以医疗互联网科技助力“健康中国”的实践者;智医、惠民,促进医疗资源下沉至基层的社会责任承担者;全球化视野、国际化资源配置的无畏开拓者。针对中国医疗改革分级诊断未来大方向以及中国家庭医生现阶段缺乏标准化工作流程、培训和服务等痛点,打造核心产品“智医惠民家庭医生云端工作系统”,为中国家庭医生及其真实应用场景提供线上一站式解决方案。

AGENDA
13:00-13:30
Registration
13:30-13:40
NECINA Introduction - Fan Wu
13:40-14:00
Dennis Grishin
14:00-14:20
Data Driven CT Radiation Dose Monitoring and Imaging Protocol Management – Introduction from a data science perspective  - Da Zhang
14:20-14:40
AI in Healthcareast, Present, and Future  - Cao (Danica) Xiao
15:00-15:20
Applications of Deep Learning in Biomedical Research and Healthcare - Zhang Chen
15:20-15:40
Deep-learning Chemical Microscopy - Jixin Cheng
15:40-16:00
Panel Discussion

16:00-16:40
Start-Up Showcase:
* VitaData
* Nebula Genomics
* ChaveTech
* Vibronix, Inc.
Moderator:
    Tingting Xu



焦点图显示:

到期时间:
回复

使用道具 举报

您需要登录后才可以回帖 登录 | 立即注册

本版积分规则

推荐阅读 More>
广告位

Powered by Boston Web Power
技术支持:Boston Web Power

© 2008-2016 波士顿万家网

合作伙伴

返回顶部 返回列表